Ali Akbar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Akbar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Abdulaziz Saleh Alkhoshaiban
Unit of Scientific Research, Applied College Qassim University Saudi Arabia
2 shared publicationsHesham M. Hassan
Department of Pathology, College of Medicine King Khalid University Abha Saudi Arabia
2 shared publications- Muhammad Faisal Hayat
Department of Zoology, Wildlife and Fisheries University of Agriculture Faisalabad Faisalabad Pakistan
2 shared publications Salim Jamil
Department of Pathology, College of Medicine King Khalid University Abha Saudi Arabia
2 shared publicationsAbdullah Alghamdi
Department of Medical Laboratory, College of Applied Medical Sciences Prince Sattam bin Abdulaziz University Al‐Kharj Saudi Arabia
1 shared publication- Abrar I. Aljohani
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia
1 shared publication
Latest Publications
- 9 November 2026
- Published by Wiley in Journal of Applied Toxicology
Venetoclax Elicits Nephrotoxicity Through TLR4/MyD88‐Mediated Innate Immune Activation and IFN‐γ Signaling
Venetoclax (VTX) is a selective B‐cell lymphoma‐2 inhibitor which is used for adults with chronic lymphocytic leukemia. However, it induces severe organ toxicity including renal impairments. The current investigation was conducted to elucidate the nephrotoxic impacts of VTX in dose‐dependent manner. Thirty‐two male Sprague–Dawley rats were randomly divided into four groups including control (normal saline through oral gavage), VTX‐low dose (50 mg/kg/day through oral gavage), VTX‐moderate dose (75 mg/kg/day through oral gavage), and VTX‐high dose (100 mg/kg/day through oral gavage) for 28 days consecutively. Gene expressions were assessed through qRT‐PCR. The levels of inflammatory, apoptotic, and renal function markers were evaluated through ELISA. Administration of VTX caused significant upregulation of Interferon‐gamma (IFNG) , Interferon gamma receptor (IFNGR1) , Signal transducer and activator of transcription 1 (STAT1) , Interferon regulatory factor 1 (IRF1), Toll‐like receptor 4 (TLR4) , Myeloid differentiation primary response 88 (MYD88) , Interleukin‐1 receptor‐associated kinase 1 (IRAK1) and Tumor necrosis factor receptor‐associated factor 6 (TRAF6) . The activity of catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), glutathione peroxidase (GPx), glutathione S‐transferase (GST), glutathione reductase (GSR) and hemeoxygenase‐1 (HO‐1) were significantly lowered while the levels of reactive oxygen species (ROS) and malondialdehyde (MDA) were augmented in response to VTX exposure in dose‐dependent manner. Moreover, VTX resulted in significant increase in the levels of urea, creatinine, uric acid, blood urea nitrogen (BUN), kidney injury marker (KIM‐1), neutrophil gelatinase‐associated lipocalin (NGAL), N‐acetyl glucosamine (NAG), cystatin C, and Endothelin‐1 alongside decreased creatinine clearance. In addition, the levels of nuclear factor kappa‐B (NF‐κB), tumor necrosis factor‐alpha (TNF‐α), interleukin‐1 beta (IL‐1β), interleukin‐6 (IL‐6), and cyclooxygenase‐2 (COX‐2) were increased following the administration of VTX. Furthermore, the levels of cysteine–aspartic acid protease‐9 (Caspase‐9), Bcl‐2‐associated X protein (Bax), and cysteine–aspartic acid protease‐3 (Caspase‐3) were upregulated while the concentrations of B‐cell lymphoma 2 (Bcl‐2) were suppressed after VTX intoxication. Besides, VTX exposure induced renal histopathological alterations including glomerular degeneration, tubular necrosis, inflammatory infiltration, vascular congestion, vacuolization of the tubular epithelial cells, tubular dilatation, interstitial oedema and marked disruption of renal architecture in a dose‐dependent manner. In silico analysis showed favorable interactions among VTX with TLR4 and STAT1, thereby predicting their involvement as molecular targets in VTX‐induced nephrotoxicity. These results show that subacute exposure to VTX causes nephrotoxicity associated with dysregulation of TLR4/MyD88 axis, IFN‐γ pathway, oxidative stress, inflammatory and apoptotic profile of renal tissues.
- 9 November 2026
- Published by Wiley in Journal of Applied Toxicology
Venetoclax Elicits Nephrotoxicity Through TLR4/MyD88‐Mediated Innate Immune Activation and IFN‐γ Signaling
Venetoclax (VTX) is a selective B‐cell lymphoma‐2 inhibitor which is used for adults with chronic lymphocytic leukemia. However, it induces severe organ toxicity including renal impairments. The current investigation was conducted to elucidate the nephrotoxic impacts of VTX in dose‐dependent manner. Thirty‐two male Sprague–Dawley rats were randomly divided into four groups including control (normal saline through oral gavage), VTX‐low dose (50 mg/kg/day through oral gavage), VTX‐moderate dose (75 mg/kg/day through oral gavage), and VTX‐high dose (100 mg/kg/day through oral gavage) for 28 days consecutively. Gene expressions were assessed through qRT‐PCR. The levels of inflammatory, apoptotic, and renal function markers were evaluated through ELISA. Administration of VTX caused significant upregulation of Interferon‐gamma (IFNG) , Interferon gamma receptor (IFNGR1) , Signal transducer and activator of transcription 1 (STAT1) , Interferon regulatory factor 1 (IRF1), Toll‐like receptor 4 (TLR4) , Myeloid differentiation primary response 88 (MYD88) , Interleukin‐1 receptor‐associated kinase 1 (IRAK1) and Tumor necrosis factor receptor‐associated factor 6 (TRAF6) . The activity of catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), glutathione peroxidase (GPx), glutathione S‐transferase (GST), glutathione reductase (GSR) and hemeoxygenase‐1 (HO‐1) were significantly lowered while the levels of reactive oxygen species (ROS) and malondialdehyde (MDA) were augmented in response to VTX exposure in dose‐dependent manner. Moreover, VTX resulted in significant increase in the levels of urea, creatinine, uric acid, blood urea nitrogen (BUN), kidney injury marker (KIM‐1), neutrophil gelatinase‐associated lipocalin (NGAL), N‐acetyl glucosamine (NAG), cystatin C, and Endothelin‐1 alongside decreased creatinine clearance. In addition, the levels of nuclear factor kappa‐B (NF‐κB), tumor necrosis factor‐alpha (TNF‐α), interleukin‐1 beta (IL‐1β), interleukin‐6 (IL‐6), and cyclooxygenase‐2 (COX‐2) were increased following the administration of VTX. Furthermore, the levels of cysteine–aspartic acid protease‐9 (Caspase‐9), Bcl‐2‐associated X protein (Bax), and cysteine–aspartic acid protease‐3 (Caspase‐3) were upregulated while the concentrations of B‐cell lymphoma 2 (Bcl‐2) were suppressed after VTX intoxication. Besides, VTX exposure induced renal histopathological alterations including glomerular degeneration, tubular necrosis, inflammatory infiltration, vascular congestion, vacuolization of the tubular epithelial cells, tubular dilatation, interstitial oedema and marked disruption of renal architecture in a dose‐dependent manner. In silico analysis showed favorable interactions among VTX with TLR4 and STAT1, thereby predicting their involvement as molecular targets in VTX‐induced nephrotoxicity. These results show that subacute exposure to VTX causes nephrotoxicity associated with dysregulation of TLR4/MyD88 axis, IFN‐γ pathway, oxidative stress, inflammatory and apoptotic profile of renal tissues.
- 2 June 2026
- Published by Wiley in Journal of Applied Toxicology
Repaglinide Provokes Dose‐Dependent Myocardial Toxicity via Disrupting HIF‐1α, TLR4/MyD88, and NF‐κB Pathway: A Biochemical, Radiological, and Histological Approach
Repaglinide (RPG) is a commonly prescribed oral antihyperglycemic agent for the control of postprandial hyperglycemia. However, the safety profile of RPG regarding cardiac tissues has not been explored yet. The present study examined the cardiotoxic effects of RPG in male Sprague Dawley rats at different doses using integrated molecular, biochemical, functional and histopathological approaches. Thirty‐two rats were randomly allocated to four groups ( n = 8), that is, control and RPG‐treated (0.7, 1.4, and 4 mg/kg/day) groups for 4 weeks. RPG administration significantly upregulated hypoxia‐angiogenic markers (HIF‐1α, VEGF‐A, VEGFR‐2, and EPO) and downregulated ANGPT1, which is suggestive of disrupted vascular stabilization. A strong inflammatory response was noticed with marked activation of TLR4/MyD88/NF‐κB signaling and increased COX‐2, IL‐6, IL‐1β, and TNF‐α expression. Oxidative stress was markedly increased at a dose‐dependent manner, as shown by degradation in antioxidant enzyme (CAT, SOD, GSR, GPx, GST, and HO‐1,) and high increments in MDA and ROS levels. Echocardiographic analysis showed a gradual low heart rate, ventricular dilation, thickening of the ventricular walls, and increasing of EDV and ESV, which is a sign of structural remodeling and impairment of the ventricle. Serum cardiac biomarkers (CK‐MB, CPK, Troponin‐I, Troponin‐T, LDH, BNP, NT‐proBNP, and CRP) were significantly elevated following the administration of RPG at varying concentrations. Apoptotic signaling was activated significantly as shown by the increased levels of Bax, Caspase‐3, and Caspase‐9 with reduced expression of Bcl‐2 after RPG intoxication. Moreover, RPG exposure induced histopathological alterations including degenerative myocardial lesions, interstitial edema, inflammatory infiltration, and early fibrotic changes. Collectively, these results show that RPG causes profound cardiotoxicity in a dose‐dependent manner, mediated by oxidative stress, inflammatory activation, hypoxia‐angiogenic imbalance, apoptotic signaling, and structural remodeling. This study demonstrates the importance of thorough cardiovascular safety evaluation of antidiabetic therapies and calls for further translational evaluation to evaluate potential clinical implications.
- 2 June 2026
- Published by Wiley in Journal of Applied Toxicology
Repaglinide Provokes Dose‐Dependent Myocardial Toxicity via Disrupting HIF‐1α, TLR4/MyD88, and NF‐κB Pathway: A Biochemical, Radiological, and Histological Approach
Repaglinide (RPG) is a commonly prescribed oral antihyperglycemic agent for the control of postprandial hyperglycemia. However, the safety profile of RPG regarding cardiac tissues has not been explored yet. The present study examined the cardiotoxic effects of RPG in male Sprague Dawley rats at different doses using integrated molecular, biochemical, functional and histopathological approaches. Thirty‐two rats were randomly allocated to four groups ( n = 8), that is, control and RPG‐treated (0.7, 1.4, and 4 mg/kg/day) groups for 4 weeks. RPG administration significantly upregulated hypoxia‐angiogenic markers (HIF‐1α, VEGF‐A, VEGFR‐2, and EPO) and downregulated ANGPT1, which is suggestive of disrupted vascular stabilization. A strong inflammatory response was noticed with marked activation of TLR4/MyD88/NF‐κB signaling and increased COX‐2, IL‐6, IL‐1β, and TNF‐α expression. Oxidative stress was markedly increased at a dose‐dependent manner, as shown by degradation in antioxidant enzyme (CAT, SOD, GSR, GPx, GST, and HO‐1,) and high increments in MDA and ROS levels. Echocardiographic analysis showed a gradual low heart rate, ventricular dilation, thickening of the ventricular walls, and increasing of EDV and ESV, which is a sign of structural remodeling and impairment of the ventricle. Serum cardiac biomarkers (CK‐MB, CPK, Troponin‐I, Troponin‐T, LDH, BNP, NT‐proBNP, and CRP) were significantly elevated following the administration of RPG at varying concentrations. Apoptotic signaling was activated significantly as shown by the increased levels of Bax, Caspase‐3, and Caspase‐9 with reduced expression of Bcl‐2 after RPG intoxication. Moreover, RPG exposure induced histopathological alterations including degenerative myocardial lesions, interstitial edema, inflammatory infiltration, and early fibrotic changes. Collectively, these results show that RPG causes profound cardiotoxicity in a dose‐dependent manner, mediated by oxidative stress, inflammatory activation, hypoxia‐angiogenic imbalance, apoptotic signaling, and structural remodeling. This study demonstrates the importance of thorough cardiovascular safety evaluation of antidiabetic therapies and calls for further translational evaluation to evaluate potential clinical implications.
- 20 February 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (3) , e70752
Nephroprotective Potential of Tectorigenin Against Thiamethoxam Instigated Renal Toxicity Via Regulating HMGB1/RAGE, TLR4/MyD88, and NF‐κB Pathway in Sprague Dawley Rats: An In‐Vivo and In‐Silico Investigation
Thiamethoxam (TMX) is a systemic neonicotinoid insecticidal agent that has been reported to damage different organs including the kidneys. Tectorigenin (TRG) is a novel isoflavone that exhibits substantial pharmacological properties. The present research trial was conducted to elucidate the nephroprotective potential of TRG to avert TMX induced renal impairments. Thirty‐six male albino rats ( n = 36) were categorized into following groups i.e., control, TMX (31.26 mg kg −1 ), TMX (31.26 mg kg −1 ) + TRG (25 mg kg −1 ), and TRG (25 mg kg −1 ) treated group. Our results showed that TMX intoxication increased the expression of interleukin‐6 (IL‐6), Receptor for Advanced Glycation End‐products (RAGE), Toll‐like receptor 4 (TLR4), tumor necrosis factor‐alpha (TNF‐α), High‐Mobility Group Box 1 (HMGB1), Cyclooxygenase‐2 (COX‐2), Myeloid Differentiation Primary Response Gene 88 (MyD88), nuclear homoeotic factor beta (NF‐κB), and interleukin‐1 beta (IL‐1β). The enzymatic activities of heme‐oxygenase‐1 (HO‐1), glutathione S‐transferase (GST), catalase (CAT), glutathione reductase (GSR), glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) were promoted while the concentration of MDA and ROS in renal tissues. Besides, TMX induces severe alterations in renal health profile as indicated by high concentrations of cystatin C (Cys C), NGAL, creatinine, serum uric acid, KIM‐1, BUN coupled with suppressed levels of creatinine clearance. The levels of Bax, Caspase‐3, and Caspase‐9 were found to be elevated while the levels of Bcl‐2 were reduced following the TMX exposure. Furthermore, TMX exposure disrupted renal morphology, including tubular necrosis, glomerular atrophy, interstitial inflammation, and epithelial desquamation. However, TRG therapy restored renal impairments via regulating antioxidative, anti‐apoptotic, anti‐inflammatory, and histo‐architecture. Our findings were strongly supported by in‐silico findings that demonstrated the potential binding of TRG with key regulatory genes.
- 20 February 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (3) , e70752
Nephroprotective Potential of Tectorigenin Against Thiamethoxam Instigated Renal Toxicity Via Regulating HMGB1/RAGE, TLR4/MyD88, and NF‐κB Pathway in Sprague Dawley Rats: An In‐Vivo and In‐Silico Investigation
Thiamethoxam (TMX) is a systemic neonicotinoid insecticidal agent that has been reported to damage different organs including the kidneys. Tectorigenin (TRG) is a novel isoflavone that exhibits substantial pharmacological properties. The present research trial was conducted to elucidate the nephroprotective potential of TRG to avert TMX induced renal impairments. Thirty‐six male albino rats ( n = 36) were categorized into following groups i.e., control, TMX (31.26 mg kg −1 ), TMX (31.26 mg kg −1 ) + TRG (25 mg kg −1 ), and TRG (25 mg kg −1 ) treated group. Our results showed that TMX intoxication increased the expression of interleukin‐6 (IL‐6), Receptor for Advanced Glycation End‐products (RAGE), Toll‐like receptor 4 (TLR4), tumor necrosis factor‐alpha (TNF‐α), High‐Mobility Group Box 1 (HMGB1), Cyclooxygenase‐2 (COX‐2), Myeloid Differentiation Primary Response Gene 88 (MyD88), nuclear homoeotic factor beta (NF‐κB), and interleukin‐1 beta (IL‐1β). The enzymatic activities of heme‐oxygenase‐1 (HO‐1), glutathione S‐transferase (GST), catalase (CAT), glutathione reductase (GSR), glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) were promoted while the concentration of MDA and ROS in renal tissues. Besides, TMX induces severe alterations in renal health profile as indicated by high concentrations of cystatin C (Cys C), NGAL, creatinine, serum uric acid, KIM‐1, BUN coupled with suppressed levels of creatinine clearance. The levels of Bax, Caspase‐3, and Caspase‐9 were found to be elevated while the levels of Bcl‐2 were reduced following the TMX exposure. Furthermore, TMX exposure disrupted renal morphology, including tubular necrosis, glomerular atrophy, interstitial inflammation, and epithelial desquamation. However, TRG therapy restored renal impairments via regulating antioxidative, anti‐apoptotic, anti‐inflammatory, and histo‐architecture. Our findings were strongly supported by in‐silico findings that demonstrated the potential binding of TRG with key regulatory genes.